What are the rates of and factors associated with discontinuation and subsequent reinitiation of glucagon-like peptide-1 receptor agonists (GLP-1 RAs) among adults with overweight or obesity? The gene discussed is GLP1R; the disease is obesity due to melanocortin 4 receptor deficiency.